Bioqube Ventures

Foundation date

21/01/2016

Sector

#Investor

Subsector

Bioqube ventures is a specialist life sciences investment firm that focuses on early-stage investments. We cut cost, accelerate business and bring value by linking three key components: access to capital, specialized infrastructure and expertise. Our partnership with Johnson & Johnson Innovation – JLINX, is the embodiment of our mission: a multifaceted approach that enables early-stage healthcare companies to reach their full potential in a cost effective and time efficient way.

Upcoming events

Latest news

  • Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board

    Wednesday March 27th 2024

  • InnoSer partners with CR2O to offer an integrated drug discovery to clinical trials pipeline

    Tuesday March 26th 2024

  • Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy

    Monday March 25th 2024